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Abstract: Following infection, tissue-resident memory T cells (Trm) are thought to be left behind at sites
of antigen encounter to protect affected tissues against subsequent reinfection. In this issue of the Euro-
pean Journal of Immunology, however, Pascutti et al. demonstrate that both murine and human CD8+
Trm specific to seven different pathogens, including systemic, skin, and lung tissue-localized pathogens,
accumulate in the bone marrow (BM). These cells have a CD69+ phenotype, develop independently of
local antigen, and require IL-15, Blimp-1, and Hobit for their differentiation and maintenance. Following
restimulation, these cells expand and rapidly produce cytokines. While some of these responses may
protect the BM from infection, the consideration that some of these pathogens or their antigens might
never reach the BM suggests additional functional roles of BM Trm, possibly in supporting hematopoietic
functions via cytokine production following infection. It will be further interesting to determine whether
BM Trm contribute to the circulating effector pool following reinfection with tissue-localized or systemic
pathogens and whether these cells can be elicited by vaccination.
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Abstract 
Following infection, tissue resident memory T cells (Trm) are thought to be left behind at sites of 
antigen encounter to protect affected tissues against subsequent reinfection. In this issue of the 
European Journal of Immunology, however, Pascutti et al. [Eur. J. Immunol. 2019. 49: XXXX-
XXXX]  demonstrate that both murine and human CD8+ Trm specific to seven different pathogens, 
including systemic, skin and lung tissue-localized pathogens, accumulate in the bone marrow. 
These cells have a CD69+ phenotype, develop independently of local antigen and require IL-15, 
Blimp-1 and Hobit for their differentiation and maintenance. Following restimulation, these cells 
expand and rapidly produce cytokines. While some of these responses may protect the bone 
marrow from infection, the consideration that some of these pathogens or their antigens might 
never reach the bone marrow suggests additional functional roles of bone marrow Trm, possibly 
in supporting hematopoietic functions via cytokine production following infection. It will be further 
interesting to determine whether bone marrow Trm contribute to the circulating effector pool 
following reinfection with tissue-localized or systemic pathogens and whether these cells can be 
elicited by vaccination.  
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Until ten years ago, memory T cells were thought to primarily circulate through the body and either 
home to secondary lymphoid tissues for reactivation (central memory) or to sites of inflammation 
(effector memory) [1]. It was noted, however, that infection could also induce local depots of 
memory T cells which remained localized at the sites of pathogen encounter [2], sometimes for 
years [3]. These non-recirculating cell populations have subsequently been termed tissue-
resident memory (Trm) T cells. Both mouse and human CD4+ and CD8+ Trm are characterized 
by the loss of receptors which allow them to migrate back into the blood stream, including the 
sphingosine-1-phosphate receptor (S1PR1) which is down-regulated in a Krüppel-like factor 2 
(KLF2)-dependent manner due to constitutive expression of CD69 by Trm [4, 5]. In addition, Trm 
generally express integrins which anchor them in epithelia or collagen within the tissues, including 
CD103 and CD49a, respectively [6]. The establishment of Trm likely depends on expression of 
certain chemokine receptors, such as CXCR3 and CXCR6 [7], allowing their initial homing to 
peripheral sites. In addition,  various transcriptional pathways, including NOTCH1/RBPJ, Hobit, 
Blimp1 and Runx3, have been described for both Trm establishment and maintenance [3, 8]. 
Depletion of circulating T cell memory cells could demonstrate that murine Trm are sufficient to 
restrict a variety of infectious disease agents, including viruses, bacteria and fungi [9]. Depletion 
models were a vital evidence to show that lung Trm provide optimal protection against respiratory 
syncytial virus (RSV) and influenza A virus (IAV) [10, 11]. Furthermore, CD4+ Trm, which seem 
to even persist longer in lungs and require less replenishment from the peripheral blood compared 
to CD8+ Trm [11-13], protect from Bordella pertussis and Mycobacterium tuberculosis infection in 
the lung  [14, 15]. This protection does not necessarily result from superior effector functions of 
Trm cells, in which they often resemble effector memory T cells with respect to proliferation, 
cytokine production and cytotoxicity [16-18]. Instead they seem to be at the right time and the 
right place to rapidly counter re-infections.  
 In the study by Pascutti and et al. of the current issue of the European Journal of 
Immunology the authors investigate tissue residency of CD8+ T cells in seven viral and bacterial 
infections: the herpesviruses Herpes simplex (HSV), human and murine cytomegalovirus (HCMV 
and MCMV) and the Epstein Barr virus (EBV), influenza A virus (IAV), lymphocytic 
choriomeningitis virus (LCMV) and the bacterial infection Listeria monocytogenes [19]. Despite 
distinct routes of infection (intranasal, intraperitoneal, intravenous or skin-scarification) and 
distinct patterns of pathogen localization (systemic, lung-localized, skin-localized) as well as 
tropism, the authors describe that, in all cases, a pool of pathogen-specific CD8+ Trm is 
established in the bone marrow (Figure 1). Even when only infection primed CD8+ T cells are 
transferred to naïve recipient mice, a proportion of these home to the bone marrow and 
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subsequently express phenotypic and transcriptional hallmarks of Trm, including CD69, CD49a, 
CD101, and Hobit along with low levels of S1PR1 and KLF2. These murine bone marrow CD8+ 
Trm were shown to efficiently produce cytokines like IFN-g, even without restimulation, and to 
degranulate despite expressing the perforin-mediated cytotoxic machinery only at low levels. 
These findings provide evidence for the interesting possibility that Trm persist not only at the site 
of primary infection, but also as a depot in the bone marrow, even despite the absence of cognate 
antigen or inflammatory cues in the local tissue environment. 
 The authors further demonstrate that murine bone marrow Trm could be significantly 
expanded following antigen encounter or infection and, additionally, that sequential infections add 
to the total Trm pool, rather than “new” Trm replacing the “old” Trm from preceding infections. 
These findings are both particularly surprising. First, because it has been suggested that the bone 
marrow mainly maintains resting memory cells [20] and second, because  this niche was thought 
to limit the total memory T cell pool due to the requirement for direct interactions with limited 
VCAM1 and IL-7-expressing stromal cells [21, 22]. The bone marrow is known to be enriched for 
memory CD4+ T cells, which accumulate at this site following initial immune responses [21] and 
can be subsequently mobilized during secondary pathogen encounter to support antibody 
responses more efficiently than other CD4+ T cell sources [21]. The current study by Pascutti et 
al, not only suggests that CD4+ memory and CD8+ Trm occupy the same niche within the bone 
marrow [22], possibly with CD4+ T cells preferentially utilizing IL-7 and CD8+ T cells preferentially 
utilizing IL-15 as their respective survival cytokines [23], but further, that, unlike CD4+ T cell 
memory, CD8+ Trm can expand during secondary immune responses at this site without any 
obvious limitations and may not be mobilized into the periphery at high numbers like CD4+ cells.  
 What then, is the role for these pathogen-specific bone marrow CD8+ Trm in host 
protection? The most straightforward possibility is that they restrict subsequent infections at this 
site. Protection from EBV infection in the bone marrow represents an interesting example. The 
authors of this study found that EBV specific human CD8+ T cells, despite being present at half 
the frequency of HCMV specific CD8+ T cells in the bone marrow, were enriched in CD69+ Trm 
cells. Previously it had been demonstrated that lytic EBV antigen (BZLF1)-specific CD8+ T cells 
were preferentially enriched in human bone marrow, while latent EBV antigen (EBNA3A)-specific 
CD8+ T cells were difficult to detect [24]. Lytic EBV replication can be primarily observed in plasma 
cells in healthy EBV carriers [25]. Additionally, co-infection with the Kaposi sarcoma associated 
herpesvirus, which stimulates plasma cell differentiation in EBV infected B cells, increases lytic 
EBV replication [26]. It is known that, following infection, the bone marrow is enriched for plasma 
cells which are maintained for years due to the survival-promoting tissue niche, providing VCAM-
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1, APRIL and BAFF signaling [27]. Thus, immune restriction of lytic EBV infection in bone marrow-
localized plasma cells could benefit from a Trm compartment that recognizes early lytic EBV 
proteins. Furthermore, CD8+ T cell responses against such early lytic EBV antigens have indeed 
been shown to diminish lytic EBV replication in an in vivo model of EBV infection [28]. Thus, a 
Trm depot could specifically protect the important hematopoietic compartment from re-infections 
or chronic infection reactivation in the bone marrow. 
 Alternatively, the bone marrow may act as a reservoir for CD8+ Trm specific for pathogens, 
which preferentially infect other tissue sites. In this case, following reinfection, these bone marrow 
Trm might be mobilized and migrate to the affected tissues to provide protective functions, as has 
been previously demonstrated for CD4+ memory T cells with a tissue residency profile [21]. Such 
a scenario would also be interesting from the perspective of vaccination. As vaccines are typically 
administrated at one site (i.e. the deltoid muscle) to protect from infection at another site (i.e. the 
respiratory tract), the generation of a bone marrow Trm intermediate which could act as a source 
for protective memory T cells would be an intriguing possibility.  
Pascutti et al., however, raise an interesting additional possible role for these bone 
marrow-localized CD8+ Trm, namely that the preferential cytokine producing function of these 
cells, either with or without restimulation, could support steady-state or emergency hematopoiesis 
[29]. Along these lines it was already shown that IFN-g by CD8+ T cells promotes myelopoiesis 
either by stimulating hematopoietic stem cells (HSCs) directly into proliferation [30] or myeloid 
progenitor cells while retaining HSC quiescence [31, 32]. These functions were suggested to 
result either from a direct effect of IFN-g on these hematopoietic stem and progenitor cell 
populations [30, 31] or via IFN-g stimulated IL-6 production by bone marrow mesenchymal stem 
cells [33]. Therefore, infections could elicit a CD8+ Trm cell population in the bone marrow which 
would support hematopoiesis and stimulate myelopoiesis that would, in turn, support tissue repair 
following infections. Such a positive feed-back loop for improved hematopoiesis after local and 
systemic infections via Trm cells in the bone marrow is an attractive theory that would need to be 
further substantiated in future studies. Nevertheless, the accumulation of CD8+ Trm in the bone 
marrow after infection, independent of the presence of the causative viruses or bacterium in this 
tissue, provides a new perspective on the role and functions of T cell tissue residency. 
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Figure legend 
Figure 1: CD8+ T cell tissue residency after lung infection, for example by the influenza A virus. 
Infections in the lung prime CD8+ T cell responses in the draining lymph nodes. Some of these 
home into the lung and establish tissue residency after the infection has been cleared. In this 
issue of the European Journal of Immunology Pascutti et al. demonstrate that some of the primed 
CD8+ T cells also establish tissue residency in the bone marrow and continue IFN-g production at 
this site. This figure was created in part with modified Servier Medical Art templates, which are 
licensed under a Creative Commons Attribution 3.0 unported license: https://smart.servier.com. 
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